453 Validation of pharmacodynamic assays to determine the clinical effect of an antisense to the XIAP inhibitor of apoptosis

Citation

• Cummings, J., Ward, T. H., LaCasse, E., Lefebvre, C., St.-Jean, M., Dawson, M., . . . Dive, C. (2004). 453 Validation of pharmacodynamic assays to determine the clinical effect of an antisense to the XIAP inhibitor of apoptosis. European Journal of Cancer Supplements, 2(8), 135. doi:10.1016/s1359-6349(04)80461-0

Digital Object Identifier (doi)

• 10.1016/s1359-6349(04)80461-0

Web Of Science Accession Number

Start Page

• 135

Volume

• 2

Issue

• 8

Abstract

UOW Authors

•   Ranson, Marie

Publication Date

• 2004

Publisher

• Elsevier BV 

Published In

• European Journal of Cancer Supplements  Journal

Citation

• Cummings, J., Ward, T. H., LaCasse, E., Lefebvre, C., St.-Jean, M., Dawson, M., . . . Dive, C. (2004). 453 Validation of pharmacodynamic assays to determine the clinical effect of an antisense to the XIAP inhibitor of apoptosis. European Journal of Cancer Supplements, 2(8), 135. doi:10.1016/s1359-6349(04)80461-0

Digital Object Identifier (doi)

• 10.1016/s1359-6349(04)80461-0

Web Of Science Accession Number

Start Page

• 135

Volume

• 2

Issue

• 8